Haemonetics Corporation
$5.68B- Market cap
- $4.68B
- Debt
- +$1.24B
- Cash
- −$245.44M
Capital structure 79% equity / 21% debt · EV / Revenue 4.26x · EV / EBITDA 21.59x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: HAE stock price at premium vs PSA $102.95 current versus $68.72 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PSA's multiple
Implied fair value · at HAE's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Expensive
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: HAE FY 2026 (ended Mar 28, 2026) · PSA FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
12 fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 79% equity / 21% debt · EV / Revenue 4.26x · EV / EBITDA 21.59x
Capital structure 84% equity / 16% debt · EV / Revenue 13.06x · EV / EBITDA 17.97x
PSA carries the larger enterprise value at $62.98B against $5.68B; HAE trades on the lower EV / Revenue multiple (4.26x vs 13.06x); PSA on the lower EV / EBITDA (17.97x vs 21.59x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Haemonetics Corporation · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Public Storage · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.56x
1.11x
Net debt / EBITDA
Leverage against operating earnings
3.80x
2.83x
Cash and equivalents
Liquid reserves on the balance sheet
$245.44M
$318.10M
Total debt
Interest-bearing obligations outstanding
$1.24B
$10.25B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BECTON DICKINSON & CO
HAE vs BDX
BAXTER INTERNATIONAL INC
HAE vs BAX
LivaNova PLC
HAE vs LIVN
STERIS plc
HAE vs STE
National Storage Affiliates Trust
HAE vs NSA
Prologis, Inc.
HAE vs PLD
WEYERHAEUSER CO
HAE vs WY
COSTAR GROUP, INC.
HAE vs CSGP
WELLTOWER INC.
HAE vs WELL
UDR, Inc.
HAE vs UDR
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.